STOCK TITAN

Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on Virtuix Holdings Inc.

(Very Positive)
Tags

Emerging Growth Research (EGR) released an updated, company-sponsored Fiscal Q1 2027 quarterly research update on Virtuix Holdings (NASDAQ: VTIX), clarifying its paid relationship with Virtuix and related conflicts of interest. The report reviews Virtuix’s financial and operational performance, including Omni One demand and segment initiatives.

According to the update, new Omni One orders rose approximately 72% year-over-year in the fiscal first quarter and are up about 150% since the launch of Omni One for Quest, a Meta-certified product. Gross profit increased roughly 29% year-over-year, with gross margin expanding from about 17% to 30%. Virtuix ended the quarter with around $7.4 million in cash.

The report highlights ongoing expansion in defense (including the U.S. Marine Corps Infantry Fireteam Trainer, counter‑UAS training and U.S. Air Force SBIR-supported work), enterprise and robotics (such as humanoid robot teleoperation), and healthcare and NASA applications, including selection for NASA’s Moon and Mars Exploration Analog mission. EGR discloses it was paid $33,000 for this company-sponsored research and may receive additional compensation.

Loading...
Loading translation...

Positive

  • Omni One orders +72% YoY in fiscal Q1 2027
  • Omni One orders +150% since Omni One for Quest launch
  • Gross profit increased approximately 29% YoY
  • Gross margin expanded from about 17% to roughly 30%
  • Cash balance of approximately $7.4 million at quarter-end
  • Broader market footprint across defense, enterprise, healthcare, robotics and NASA applications

Negative

  • Quarterly update is company-sponsored research, not independent coverage
  • Emerging Growth Research received $33,000 in compensation from Virtuix for this report
  • Stated conflict of interest as both EGR and EmergingGrowth.com may receive fees tied to Virtuix coverage

Market Context

Historical event 1495320 showed a -22.53% 24-hour reaction, illustrating divergence between operatin...
Analysis

Historical event 1495320 showed a -22.53% 24-hour reaction, illustrating divergence between operating highlights and market response. For this sponsored update, the disclosed $33,000 payment and recent insider net selling were risks to monitor.

Key Figures

New Omni One orders: 72% Orders since Meta launch: 150% Gross profit growth: 29% +3 more
6 metrics
New Omni One orders 72% Fiscal first quarter, year-over-year
Orders since Meta launch 150% Since Omni One for Quest launch
Gross profit growth 29% Year-over-year
Gross margin 30% Fiscal first quarter, from 17% in the prior-year period
Cash $7.4 million End of fiscal first quarter
Research compensation $33,000 Paid to Emerging Growth Research

Historical Context

5 past events · Latest: Aug 26 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 26 Research rating reiteration Positive +12.4% Research firm reiterated its rating and price target following fiscal Q1 results.
Aug 19 Fiscal Q1 earnings Positive -22.5% Orders and gross margin improved, but the company reported lower sales and a wider net loss.
Aug 13 Investor conference presentation Neutral +1.2% Virtuix scheduled a conference presentation and fiscal Q1 results discussion.
Aug 12 Results release rescheduling Neutral +1.2% Virtuix rescheduled fiscal Q1 results after transitioning to a new independent accounting firm.
Aug 05 Defense trainer advancement Positive +5.3% Virtuix selected AVRT for weapons tracking and training content for its Marine Corps trainer.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historical reactions were mixed: one positive operating update diverged negatively, while other favorable announcements aligned with positive price reactions.

Key Terms

company-sponsored research, sbir, counter-uas
3 terms
company-sponsored research financial
"The research referenced in this press release is company-sponsored research."
Research that a company pays for, commissions, or controls so it can produce information about its own business, products, strategies, markets, or financial outlook. Investors care because the company’s role in funding or directing the work can create a potential bias in what is emphasized or omitted; think of it like a product review written by the manufacturer rather than an independent reviewer, which can still be useful but may require extra scrutiny.
sbir regulatory
"U.S. Air Force SBIR-supported development."
SBIR stands for Small Business Innovation Research, a government program that gives grants or contracts to small companies to develop and test new technologies. Think of it as a government-funded pilot customer that pays a startup to prove its idea works, which lowers development cost and risk. For investors, SBIR awards signal third-party validation, provide non-dilutive funding, and can open pathways to larger government contracts or commercial markets.
counter-uas technical
"counter-UAS training applications"
Counter-UAS (counter-unmanned aircraft systems) are tools and tactics used to detect, track, and disable or divert drones that pose a threat to people, property, or operations. Think of them as a combination of a security camera, alarm system, and net that can find an unwanted flying device and stop it before it causes harm. Investors care because demand, regulation, and deployment of these systems affect revenue, contract opportunities, legal risk, and the valuation of companies that build or use them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update on Virtuix Holdings Inc. (NASDAQ:VTIX), a leading developer of AI-driven, full-body simulation systems for consumer, enterprise, healthcare and defense applications.

This release is being issued as an updated version of EGR's previously published press release regarding its Fiscal Q1 2027 Quarterly Update on Virtuix Holdings Inc. The updated release is intended to clarify the company-sponsored nature of the research and provide additional disclosure regarding EGR's financial relationship with the Company.

The Fiscal Q1 2027 Quarterly Update reviews Virtuix's recent financial and operational performance, consumer demand following the launch of Omni One for Quest in collaboration with Meta, and continued expansion across the Company's defense, enterprise, healthcare and robotics initiatives.

Key Highlights

  • Strong New Order Momentum - Virtuix reported that new Omni One orders increased approximately 72% year-over-year during the fiscal first quarter, with orders increasing approximately 150% since the launch of Omni One for Quest.

  • Improved Gross Margin - Gross profit increased approximately 29% year-over-year, while gross margin expanded to approximately 30% from 17% in the prior-year period.

  • Consumer Market Expansion - The launch of the Meta-certified Omni One for Quest has expanded Virtuix's access to the broader consumer virtual reality market and contributed to accelerating order activity.

  • Defense Market Expansion - Virtuix continues to advance its defense initiatives, including its U.S. Marine Corps Infantry Fireteam Trainer, counter-UAS training applications and U.S. Air Force SBIR-supported development.

  • Enterprise and Robotics Applications - The Company has expanded Omni One Enterprise applications into areas including humanoid robot teleoperation and simulation.

  • Healthcare and NASA Applications - Virtuix continues to develop applications for healthcare and therapeutic markets and has been selected for NASA's Moon and Mars Exploration Analog mission.

  • Financial Position - Virtuix ended the fiscal first quarter with approximately $7.4 million in cash.

The full Fiscal Q1 2027 Quarterly Update from Emerging Growth Research is available at:

https://storage.googleapis.com/accesswire/media/1213656/vtixq1fy27-quarerly-update-082626.pdf

Or

https://emerginggrowth.com/profile/vtix/ (on the right side of the page as you scroll down)

About Virtuix Holdings Inc.

Virtuix Holdings Inc. (NASDAQ:VTIX) is a leading manufacturer of AI-driven, full-body simulation systems for consumer, enterprise, and defense markets. The company's premier portfolio of "Omni" omni-directional treadmills enables players to walk and run in 360 degrees without boundaries inside AI-generated worlds. With a focus on immersive entertainment, defense training, and enterprise applications, Virtuix continues to push the boundaries of full-body XR and AI-driven immersive experiences for users worldwide. For more information, please visit www.Virtuix.com.

About Emerging Growth Research

Emerging Growth Research, LLC ("EGR") is a research firm focused on emerging growth companies, including small-, micro- and nano-cap companies across healthcare, biotechnology, energy, metals and mining, technology and other emerging industries. EGR provides research reports, quarterly updates, flash reports and other investor-focused content covering emerging growth companies.

Emerging Growth Research also provides company-sponsored research services. The research referenced in this press release is company-sponsored research.

Contact:

Emerging Growth Research
Research@EmergingGrowth.com
www.EmergingGrowth.com

Forward-Looking Statements

This press release contains forward-looking statements concerning business operations, financial performance, revenue projections, defense contracting opportunities, merger and acquisition prospects, valuation estimates, and future growth expectations. These statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied. Important risk factors include, but are not limited to, consumer adoption rates, defense contract timing and procurement delays, geopolitical and tariff exposure, potential share dilution, the expiration of the IPO lock-up period, and the Company's ability to successfully execute its growth strategy across both consumer and defense markets.

Disclosure

This report was prepared for institutional and professional investors ONLY, and it is also known as Company Sponsored Research ("CSR"). Collectively, however ("EGR Report(s)").

Be advised that this EGR Report is being provided by Emerging Growth Research LLC (EGR) solely for informational purposes, is not the opinion of EmergingGrowth.com (EG), should not be construed as an offer or solicitation to buy or sell securities, and should not be considered in any decision to buy or sell any security mentioned within the EGR Reports. All information contained in the EGR Report as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive, timely, or correct. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. Because EGR is compensated as detailed herein and EG receives Licensing fees from EGR, as also detailed herein, EG and EGR have a conflict of interest and strongly urge you to consult your own independent financial, investment, tax, and legal advisors prior to purchasing or selling any securities mentioned herein.

The analyst that has prepared and is responsible for the content of this report has stated that neither he/she, nor any of his/her associates both professional and personal, to the best of his/her knowledge have no personal or professional relationship with any of the companies or principals of any companies mentioned within, other than providing services that EGR may offer.

EGR is being compensated by the subject Company of this report. EGR was paid thirty-three thousand dollars and does not expect to receive an additional amount over the following nine months. EGR may have also received additional past compensation, EGR may receive future compensation, and EG may receive compensation for additional services such as presenting on the Emerging Growth Conference or investor or public relations services, details about which can be found in the full disclosure, here: https://emerginggrowth.com/virtuix-holdings-egr-report-disclosure/.

It is the intent of EGR to provide continuing coverage on a quarterly basis, or otherwise for the subject Company of this report; however, EGR and EG will not notify readers of this report if coverage by EGR, for any reason is terminated.

The reader or user of this content agrees that neither EGR and / or EG nor the analysts, directors, officers, employees, representatives, independent contractors, agents or affiliates of EGR and EG shall be liable or held liable for any omissions, errors, or inaccuracies, regardless of cause, foreseeability, or the lack of timeliness of this or any of our other reports to users. This lack of liability extends to direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, losses, lost income, lost profit, or opportunity costs.

Again, all information contained herein should be independently verified by your own research and your own independent financial, investment, tax, and legal advisors prior to purchasing or selling any securities mentioned herein.

In addition to the specific disclosures mentioned herein, you are encouraged to read our general disclosure here: EmergingGrowth.com/Disclosure.

Rating Definitions

Buy, 30% or greater price appreciation in the next 12 months.

Buy-Extended, near-term EPS and/or revenue horizon is challenging with strong long-term appreciation possibility.

Buy-Emerging, initial stages with low revenue and the potential for large returns with higher risk and volatility.

Hold, perform similar to market.

Sell, 30% or more decline in the next 12 months.

© Copyright 2026 Emerging Growth Research LLC

No part of this material may be copied, photocopied, or duplicated in any form by any means or redistributed without the prior written consent of Emerging Growth Research LLC.

SOURCE: Virtuix Holdings Inc.



View the original press release on ACCESS Newswire

FAQ

What did the Emerging Growth Research Q1 2027 update say about Virtuix Holdings (NASDAQ: VTIX) order growth?

According to Emerging Growth Research, Virtuix reported Omni One orders rose about 72% year-over-year in fiscal Q1 2027. The update also notes orders increased approximately 150% since the launch of Omni One for Quest, indicating significantly higher demand following the Meta-certified product introduction.

How did Virtuix Holdings (VTIX) gross margin change in Fiscal Q1 2027?

According to Emerging Growth Research, Virtuix’s gross margin expanded to roughly 30% in fiscal Q1 2027 from about 17% a year earlier. Gross profit increased approximately 29% year-over-year, reflecting higher profitability on sales during the reported quarter compared with the prior-year period.

What cash position for Virtuix Holdings (NASDAQ: VTIX) is disclosed in the Q1 2027 update?

According to Emerging Growth Research, Virtuix ended its fiscal first quarter with approximately $7.4 million in cash. This cash balance is presented as part of the company’s financial position within the sponsored research update for institutional and professional investors reviewing Virtuix.

Is the Emerging Growth Research report on Virtuix Holdings (VTIX) company-sponsored and how is EGR compensated?

Yes, the report is company-sponsored research. According to Emerging Growth Research, it was paid thirty-three thousand dollars by Virtuix for this report and may receive additional compensation, creating a disclosed conflict of interest for readers to consider when using the analysis.

What markets and applications for Virtuix Holdings (VTIX) are highlighted in the Q1 2027 research update?

According to Emerging Growth Research, Virtuix is active in consumer VR, defense, enterprise, healthcare, robotics and NASA-related applications. Examples include the U.S. Marine Corps Infantry Fireteam Trainer, counter‑UAS training, humanoid robot teleoperation, therapeutic healthcare uses and NASA’s Moon and Mars Exploration Analog mission.

Where can investors access the Emerging Growth Research Q1 2027 report on Virtuix Holdings (NASDAQ: VTIX)?

According to Emerging Growth Research, the full Fiscal Q1 2027 update on Virtuix is available via a hosted PDF link and on EmergingGrowth.com. On EmergingGrowth.com, investors can find it on the Virtuix profile page, located on the right side as they scroll.

What risk and conflict of interest disclosures accompany the Virtuix Holdings (VTIX) research from Emerging Growth Research?

According to Emerging Growth Research, the report is informational only, not investment advice, and involves forward-looking statements and potential risks. EGR and EmergingGrowth.com disclose compensation from Virtuix and licensing fees, emphasizing a conflict of interest and urging independent financial, tax and legal advice.